Gene Symbol | Gene ID | Gene Info |
---|---|---|
Meox1
|
ENSMUSG00000001493.9 | mesenchyme homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_101894392_101894543 | Meox1 | 93 | 0.952284 | 0.47 | 2.7e-04 | Click! |
chr11_101896932_101897309 | Meox1 | 2746 | 0.178333 | 0.28 | 4.1e-02 | Click! |
chr11_101910340_101910491 | Meox1 | 16041 | 0.105443 | 0.09 | 5.0e-01 | Click! |
chr11_101896624_101896800 | Meox1 | 2338 | 0.198842 | 0.07 | 6.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_112001700_112002600 | 19.04 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr5_33542035_33542598 | 16.77 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr1_24612739_24612914 | 15.42 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chr3_157732464_157732921 | 15.18 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr6_138424907_138425582 | 14.37 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr1_80408527_80409167 | 14.00 |
Gm6189 |
predicted gene 6189 |
23662 |
0.13 |
chr1_24613351_24614205 | 13.38 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr14_14351950_14353283 | 13.19 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr8_110987902_110988088 | 11.54 |
Ddx19a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 19a |
7361 |
0.11 |
chr18_42510920_42511513 | 11.08 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr8_36668721_36669167 | 11.07 |
Dlc1 |
deleted in liver cancer 1 |
55001 |
0.16 |
chr13_85126661_85127037 | 10.82 |
Gm4076 |
predicted gene 4076 |
665 |
0.69 |
chr3_144174293_144174609 | 10.55 |
Lmo4 |
LIM domain only 4 |
20367 |
0.17 |
chr1_162216776_162217075 | 10.39 |
Dnm3os |
dynamin 3, opposite strand |
698 |
0.48 |
chr7_109174643_109175577 | 10.17 |
Lmo1 |
LIM domain only 1 |
97 |
0.97 |
chr7_109191268_109192295 | 10.12 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr5_137349031_137350198 | 9.94 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr2_105769867_105770156 | 9.92 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr3_79144987_79146081 | 9.66 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
341 |
0.91 |
chr6_146981244_146981874 | 9.08 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr8_108703603_108704102 | 8.99 |
Zfhx3 |
zinc finger homeobox 3 |
752 |
0.73 |
chrX_123943434_123943951 | 8.95 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chrX_123721926_123722462 | 8.87 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chr15_96874188_96874389 | 8.82 |
Rpl10a-ps3 |
ribosomal protein L10A, pseudogene 3 |
49117 |
0.16 |
chr4_154121558_154121709 | 8.79 |
Trp73 |
transformation related protein 73 |
5028 |
0.13 |
chrX_123271195_123271712 | 8.67 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123500550_123501093 | 8.65 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr14_76817069_76817629 | 8.55 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr2_22587496_22588353 | 8.55 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr1_166002288_166003185 | 8.33 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr3_96251008_96251159 | 8.21 |
Gm20627 |
predicted gene 20627 |
4386 |
0.04 |
chr3_121530937_121531224 | 8.20 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
539 |
0.67 |
chr13_77548432_77549057 | 8.14 |
Gm9634 |
predicted gene 9634 |
5629 |
0.31 |
chr7_142025647_142025813 | 8.08 |
Mob2 |
MOB kinase activator 2 |
221 |
0.88 |
chr13_43231981_43232458 | 7.85 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr11_103132227_103133103 | 7.77 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
chr14_8286642_8286923 | 7.70 |
Fam107a |
family with sequence similarity 107, member A |
22995 |
0.16 |
chr19_43767999_43768210 | 7.63 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr7_5060805_5061447 | 7.62 |
Gm45133 |
predicted gene 45133 |
923 |
0.22 |
chr12_79674954_79675872 | 7.57 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr7_29070679_29071390 | 7.56 |
Gm26604 |
predicted gene, 26604 |
569 |
0.5 |
chr5_121889411_121889760 | 7.44 |
Cux2 |
cut-like homeobox 2 |
5796 |
0.15 |
chr11_44508913_44509245 | 7.44 |
Rnf145 |
ring finger protein 145 |
9885 |
0.16 |
chr8_120549369_120550473 | 7.27 |
Mir7687 |
microRNA 7687 |
11225 |
0.1 |
chr4_116720426_116721428 | 7.21 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr8_91331323_91331874 | 7.18 |
Fto |
fat mass and obesity associated |
17984 |
0.13 |
chr13_43480925_43481874 | 7.13 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr5_137786077_137787112 | 7.12 |
Mepce |
methylphosphate capping enzyme |
69 |
0.92 |
chr11_100938783_100940230 | 7.11 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr1_68666889_68667107 | 7.07 |
Gm37735 |
predicted gene, 37735 |
26169 |
0.2 |
chr15_100599610_100600576 | 7.06 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr12_51907627_51907778 | 7.04 |
Heatr5a |
HEAT repeat containing 5A |
11024 |
0.21 |
chr18_56870554_56870904 | 7.02 |
Gm18087 |
predicted gene, 18087 |
45359 |
0.14 |
chr18_35848127_35849279 | 6.88 |
Cxxc5 |
CXXC finger 5 |
5984 |
0.11 |
chr5_116023179_116023683 | 6.82 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
925 |
0.45 |
chr13_97825475_97826241 | 6.75 |
Gm41031 |
predicted gene, 41031 |
27 |
0.98 |
chr18_60605971_60606545 | 6.74 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr1_12409934_12410455 | 6.73 |
Mir6341 |
microRNA 6341 |
15792 |
0.23 |
chr3_116366245_116366396 | 6.73 |
Gm29151 |
predicted gene 29151 |
16217 |
0.16 |
chr6_55901966_55902527 | 6.71 |
Itprid1 |
ITPR interacting domain containing 1 |
15421 |
0.27 |
chr17_35741597_35741789 | 6.70 |
Gm20443 |
predicted gene 20443 |
1887 |
0.16 |
chr11_116014914_116015211 | 6.68 |
Galk1 |
galactokinase 1 |
2343 |
0.16 |
chr3_108562098_108562631 | 6.63 |
Tmem167b |
transmembrane protein 167B |
102 |
0.92 |
chr1_191855059_191855511 | 6.59 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
28137 |
0.12 |
chr7_143340680_143341191 | 6.50 |
Gm38095 |
predicted gene, 38095 |
3502 |
0.17 |
chr19_24535123_24535505 | 6.50 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
20475 |
0.18 |
chr8_18991275_18991446 | 6.47 |
Defb37 |
defensin beta 37 |
305 |
0.84 |
chr9_121872229_121872380 | 6.47 |
Gm47113 |
predicted gene, 47113 |
2808 |
0.12 |
chr11_98740095_98741203 | 6.45 |
Thra |
thyroid hormone receptor alpha |
11 |
0.95 |
chr14_26076728_26076880 | 6.42 |
Gm19014 |
predicted gene, 19014 |
3492 |
0.13 |
chr14_25936976_25937128 | 6.42 |
Cphx1 |
cytoplasmic polyadenylated homeobox 1 |
1252 |
0.32 |
chr1_86287512_86287782 | 6.42 |
Gm16341 |
predicted gene 16341 |
13728 |
0.09 |
chr3_144198270_144199266 | 6.42 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr12_111008305_111008501 | 6.42 |
Gm48631 |
predicted gene, 48631 |
9999 |
0.11 |
chr18_76378600_76379338 | 6.39 |
Gm50360 |
predicted gene, 50360 |
57145 |
0.14 |
chr6_42363179_42363495 | 6.38 |
2010310C07Rik |
RIKEN cDNA 2010310C07 gene |
7334 |
0.09 |
chr14_26216351_26216502 | 6.38 |
Gm19015 |
predicted gene, 19015 |
3484 |
0.15 |
chr14_48418768_48419083 | 6.32 |
Gm3534 |
predicted pseudogene 3534 |
10307 |
0.15 |
chr11_121232047_121232216 | 6.28 |
Cybc1 |
cytochrome b 245 chaperone 1 |
2809 |
0.15 |
chr9_66181229_66181417 | 6.24 |
Dapk2 |
death-associated protein kinase 2 |
23088 |
0.17 |
chr9_88483752_88484150 | 6.22 |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
1377 |
0.28 |
chr2_32418807_32418958 | 6.18 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1052 |
0.33 |
chr5_122280933_122281099 | 6.15 |
Pptc7 |
PTC7 protein phosphatase homolog |
3349 |
0.15 |
chr11_88996503_88996757 | 6.14 |
Gm11496 |
predicted gene 11496 |
86 |
0.94 |
chr15_59520085_59520242 | 6.14 |
Gm36677 |
predicted gene, 36677 |
98427 |
0.07 |
chr5_76828559_76829372 | 6.07 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
11634 |
0.19 |
chr2_160619427_160619728 | 6.04 |
Gm14221 |
predicted gene 14221 |
394 |
0.83 |
chr3_127930721_127931028 | 6.04 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14702 |
0.14 |
chr17_83659006_83659302 | 6.04 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr9_90036355_90036666 | 6.04 |
Gm17944 |
predicted gene, 17944 |
3267 |
0.24 |
chr10_120387024_120387466 | 6.02 |
9230105E05Rik |
RIKEN cDNA 9230105E05 gene |
2278 |
0.28 |
chr12_46635290_46635769 | 5.90 |
Gm48535 |
predicted gene, 48535 |
30180 |
0.15 |
chr14_99392681_99392832 | 5.90 |
Gm49219 |
predicted gene, 49219 |
5317 |
0.17 |
chr11_87725724_87726211 | 5.87 |
Rnf43 |
ring finger protein 43 |
1459 |
0.24 |
chr9_59310966_59311172 | 5.86 |
Adpgk |
ADP-dependent glucokinase |
579 |
0.77 |
chr10_62218879_62219064 | 5.85 |
Tspan15 |
tetraspanin 15 |
12280 |
0.15 |
chr3_107768719_107768871 | 5.84 |
Csf1 |
colony stimulating factor 1 (macrophage) |
8326 |
0.14 |
chr12_80114135_80114615 | 5.84 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
1362 |
0.27 |
chr6_98767823_98768513 | 5.83 |
Gm32308 |
predicted gene, 32308 |
10419 |
0.26 |
chr15_82794220_82794587 | 5.77 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr16_95382153_95382455 | 5.77 |
Gm31641 |
predicted gene, 31641 |
26628 |
0.2 |
chr16_92399556_92400502 | 5.77 |
Rcan1 |
regulator of calcineurin 1 |
48 |
0.97 |
chr14_33687535_33688054 | 5.76 |
Gm26228 |
predicted gene, 26228 |
43299 |
0.14 |
chr2_110085704_110086138 | 5.75 |
Ccdc34os |
coiled-coil domain containing 34, opposite strand |
35442 |
0.16 |
chr13_36057568_36057763 | 5.74 |
Fars2 |
phenylalanine-tRNA synthetase 2 (mitochondrial) |
59747 |
0.08 |
chr6_72097140_72098281 | 5.72 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr6_18271101_18271252 | 5.72 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
15952 |
0.16 |
chr11_60537440_60537820 | 5.70 |
Alkbh5 |
alkB homolog 5, RNA demethylase |
348 |
0.76 |
chr12_29698179_29698919 | 5.69 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
12104 |
0.29 |
chr14_71129843_71130214 | 5.67 |
Gm49289 |
predicted gene, 49289 |
42758 |
0.19 |
chr2_17510016_17510384 | 5.67 |
Nebl |
nebulette |
18124 |
0.22 |
chr5_111836465_111837021 | 5.60 |
Gm36535 |
predicted gene, 36535 |
43356 |
0.15 |
chr3_115768720_115769146 | 5.59 |
Gm9889 |
predicted gene 9889 |
53783 |
0.11 |
chr13_52822783_52823147 | 5.59 |
BB123696 |
expressed sequence BB123696 |
65760 |
0.12 |
chr17_47909349_47909983 | 5.58 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr3_103171228_103172264 | 5.57 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr1_66862302_66862580 | 5.56 |
Acadl |
acyl-Coenzyme A dehydrogenase, long-chain |
836 |
0.42 |
chr1_192799477_192799835 | 5.56 |
Gm38360 |
predicted gene, 38360 |
21471 |
0.12 |
chr4_83206835_83207691 | 5.52 |
Gm11185 |
predicted gene 11185 |
13275 |
0.19 |
chr11_94597514_94597665 | 5.49 |
Acsf2 |
acyl-CoA synthetase family member 2 |
4180 |
0.13 |
chr1_21660699_21661216 | 5.49 |
Gm7658 |
predicted gene 7658 |
147901 |
0.04 |
chr16_13276181_13276648 | 5.47 |
Mrtfb |
myocardin related transcription factor B |
11338 |
0.26 |
chr5_109557850_109558797 | 5.46 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr1_130681895_130682046 | 5.45 |
C4bp-ps1 |
complement component 4 binding protein, pseudogene 1 |
2101 |
0.19 |
chr14_79494423_79494574 | 5.44 |
Wbp4 |
WW domain binding protein 4 |
12978 |
0.15 |
chr4_103189337_103189489 | 5.43 |
Slc35d1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
25259 |
0.14 |
chr3_159839922_159840851 | 5.43 |
Wls |
wntless WNT ligand secretion mediator |
476 |
0.86 |
chr8_36639539_36639910 | 5.42 |
Dlc1 |
deleted in liver cancer 1 |
25781 |
0.24 |
chr5_60042722_60043044 | 5.41 |
Gm43393 |
predicted gene 43393 |
17000 |
0.17 |
chr18_69946685_69946957 | 5.41 |
Ccdc68 |
coiled-coil domain containing 68 |
21245 |
0.15 |
chr15_85232128_85232414 | 5.39 |
Fbln1 |
fibulin 1 |
26266 |
0.17 |
chr7_142568721_142568939 | 5.39 |
H19 |
H19, imprinted maternally expressed transcript |
7708 |
0.1 |
chr9_108338578_108339700 | 5.39 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr7_115845858_115846040 | 5.34 |
Sox6 |
SRY (sex determining region Y)-box 6 |
156 |
0.97 |
chr2_77519394_77519682 | 5.33 |
Zfp385b |
zinc finger protein 385B |
3 |
0.99 |
chr8_25074684_25075074 | 5.33 |
Plekha2 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
16467 |
0.12 |
chr2_60940262_60940686 | 5.33 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22718 |
0.21 |
chr5_144313725_144313894 | 5.31 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
24902 |
0.13 |
chr7_125559562_125559713 | 5.31 |
Il4ra |
interleukin 4 receptor, alpha |
7350 |
0.16 |
chr19_5553843_5554168 | 5.30 |
Ovol1 |
ovo like zinc finger 1 |
5398 |
0.08 |
chr4_80002679_80002838 | 5.29 |
Gm11407 |
predicted gene 11407 |
427 |
0.69 |
chr8_94898997_94899206 | 5.29 |
Ccdc102a |
coiled-coil domain containing 102A |
18420 |
0.1 |
chr18_4636780_4636931 | 5.29 |
Jcad |
junctional cadherin 5 associated |
1977 |
0.4 |
chr5_115436438_115437458 | 5.28 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr7_108797287_108797500 | 5.28 |
Gm45232 |
predicted gene 45232 |
2390 |
0.19 |
chr4_155213419_155213944 | 5.26 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
8854 |
0.18 |
chr17_56609730_56610422 | 5.26 |
Micos13 |
mitochondrial contact site and cristae organizing system subunit 13 |
305 |
0.8 |
chr7_100179963_100180114 | 5.26 |
Kcne3 |
potassium voltage-gated channel, Isk-related subfamily, gene 3 |
1322 |
0.31 |
chr12_41351050_41351632 | 5.23 |
Gm25497 |
predicted gene, 25497 |
2769 |
0.25 |
chr9_93186720_93187149 | 5.23 |
1700034K08Rik |
RIKEN cDNA 1700034K08 gene |
181195 |
0.03 |
chr16_72699156_72700074 | 5.23 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr11_32280743_32280902 | 5.21 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
2689 |
0.14 |
chr3_89280469_89281651 | 5.20 |
Efna1 |
ephrin A1 |
82 |
0.91 |
chr1_151496030_151496181 | 5.20 |
Gm36527 |
predicted gene, 36527 |
3480 |
0.14 |
chr5_43855901_43856053 | 5.20 |
Cd38 |
CD38 antigen |
12576 |
0.1 |
chr13_9019634_9019841 | 5.19 |
Gtpbp4 |
GTP binding protein 4 |
23654 |
0.1 |
chr17_45998371_45998678 | 5.19 |
Vegfa |
vascular endothelial growth factor A |
22848 |
0.14 |
chr1_77505970_77506663 | 5.18 |
Epha4 |
Eph receptor A4 |
8763 |
0.19 |
chr16_45927578_45927797 | 5.18 |
Gm15640 |
predicted gene 15640 |
8636 |
0.17 |
chr10_117518409_117518560 | 5.16 |
Gm32235 |
predicted gene, 32235 |
40615 |
0.11 |
chr10_69252889_69253040 | 5.14 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
12673 |
0.19 |
chr12_79313741_79313892 | 5.14 |
Rad51b |
RAD51 paralog B |
13537 |
0.19 |
chr16_93197838_93198066 | 5.13 |
Gm28003 |
predicted gene, 28003 |
125197 |
0.05 |
chr1_90969551_90969811 | 5.13 |
Rab17 |
RAB17, member RAS oncogene family |
20 |
0.97 |
chr6_67481043_67481194 | 5.12 |
Il23r |
interleukin 23 receptor |
10737 |
0.15 |
chr4_129218886_129219037 | 5.11 |
Yars |
tyrosyl-tRNA synthetase |
5199 |
0.13 |
chr13_97409582_97410189 | 5.10 |
Lncenc1 |
long non-coding RNA, embryonic stem cells expressed 1 |
25085 |
0.15 |
chr10_94566069_94566220 | 5.08 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
9113 |
0.17 |
chr4_98318734_98319169 | 5.06 |
0610025J13Rik |
RIKEN cDNA 0610025J13 gene |
2447 |
0.26 |
chr5_135108172_135108560 | 5.06 |
Mlxipl |
MLX interacting protein-like |
1448 |
0.24 |
chr10_70127259_70127423 | 5.06 |
Ccdc6 |
coiled-coil domain containing 6 |
30220 |
0.2 |
chr1_64087943_64089121 | 5.05 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chr15_99651541_99652191 | 5.03 |
Racgap1 |
Rac GTPase-activating protein 1 |
210 |
0.88 |
chr6_49150791_49151235 | 5.02 |
Gm18010 |
predicted gene, 18010 |
21746 |
0.13 |
chr5_97996482_97996782 | 5.01 |
Antxr2 |
anthrax toxin receptor 2 |
537 |
0.75 |
chr13_104285003_104285221 | 4.99 |
Adamts6 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6 |
2723 |
0.29 |
chr9_41105452_41105603 | 4.98 |
Gm48611 |
predicted gene, 48611 |
6554 |
0.17 |
chr11_62978995_62979146 | 4.97 |
Cdrt4os1 |
CMT1A duplicated region transcript 4, opposite strand 1 |
25058 |
0.12 |
chr10_63199151_63199302 | 4.96 |
Mypn |
myopalladin |
4726 |
0.16 |
chr13_90939682_90939863 | 4.94 |
Rps23 |
ribosomal protein S23 |
15587 |
0.21 |
chr13_60358793_60358990 | 4.92 |
Gm10779 |
predicted gene 10779 |
27442 |
0.17 |
chr11_30648868_30649937 | 4.92 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr4_28863045_28863391 | 4.90 |
Epha7 |
Eph receptor A7 |
8623 |
0.26 |
chr11_70500499_70500650 | 4.88 |
Tm4sf5 |
transmembrane 4 superfamily member 5 |
4670 |
0.08 |
chr1_162891926_162892449 | 4.86 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr6_3265625_3265784 | 4.80 |
Gm42961 |
predicted gene 42961 |
11849 |
0.12 |
chr7_141268978_141269142 | 4.79 |
Irf7 |
interferon regulatory factor 7 |
2579 |
0.11 |
chr7_127672339_127672529 | 4.78 |
Gm44760 |
predicted gene 44760 |
14200 |
0.08 |
chr9_21752605_21752820 | 4.77 |
Spc24 |
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
5107 |
0.13 |
chr19_4594702_4594853 | 4.77 |
Pcx |
pyruvate carboxylase |
369 |
0.79 |
chr10_105423144_105423438 | 4.77 |
Gm48203 |
predicted gene, 48203 |
29005 |
0.15 |
chr5_100385162_100385313 | 4.77 |
Sec31a |
Sec31 homolog A (S. cerevisiae) |
2390 |
0.25 |
chr12_83708261_83708422 | 4.75 |
Psen1 |
presenilin 1 |
16298 |
0.12 |
chr8_94966621_94966796 | 4.75 |
Gm10286 |
predicted gene 10286 |
3046 |
0.16 |
chr4_144980888_144981094 | 4.74 |
Vps13d |
vacuolar protein sorting 13D |
2970 |
0.28 |
chr4_132075006_132075723 | 4.74 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr12_52448650_52448801 | 4.73 |
Gm47431 |
predicted gene, 47431 |
600 |
0.77 |
chr11_95089292_95089443 | 4.73 |
Itga3 |
integrin alpha 3 |
12566 |
0.12 |
chr8_94962299_94962469 | 4.72 |
Gm10286 |
predicted gene 10286 |
7370 |
0.12 |
chr4_133552955_133553552 | 4.71 |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
123 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
3.3 | 9.9 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.5 | 7.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.4 | 7.3 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
2.3 | 6.8 | GO:0008050 | female courtship behavior(GO:0008050) |
2.3 | 6.8 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 5.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.8 | 8.8 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.7 | 5.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.7 | 6.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.7 | 5.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.6 | 4.9 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
1.6 | 4.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.6 | 4.8 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.5 | 6.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.5 | 4.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.5 | 5.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.5 | 7.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.4 | 4.2 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.4 | 1.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.3 | 3.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 2.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.3 | 2.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.2 | 7.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.2 | 3.6 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.2 | 3.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 3.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.1 | 3.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.1 | 3.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.1 | 3.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.1 | 6.5 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
1.1 | 3.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 5.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.1 | 3.2 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.0 | 3.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.0 | 3.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.0 | 2.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.0 | 5.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.0 | 1.9 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
1.0 | 4.8 | GO:0009249 | protein lipoylation(GO:0009249) |
1.0 | 2.9 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.9 | 2.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.9 | 2.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.9 | 4.7 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.9 | 1.9 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.9 | 2.7 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.9 | 4.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.9 | 3.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.9 | 2.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.9 | 3.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.9 | 3.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.9 | 1.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.9 | 2.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.9 | 2.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.8 | 2.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 2.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.8 | 3.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.8 | 4.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 2.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.8 | 3.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.8 | 2.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.8 | 2.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.8 | 1.6 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.8 | 2.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 8.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.8 | 3.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.8 | 0.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 3.8 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.8 | 3.0 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 3.0 | GO:0046618 | drug export(GO:0046618) |
0.7 | 1.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.7 | 2.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 2.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 9.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 1.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 3.5 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 1.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.7 | 2.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 2.1 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 2.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.7 | 2.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 4.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.7 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 1.3 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.7 | 4.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 2.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 0.7 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.7 | 2.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.7 | 3.3 | GO:0015809 | arginine transport(GO:0015809) |
0.7 | 1.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.6 | 1.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.6 | 1.9 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.6 | 4.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 1.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.6 | 1.9 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.6 | 1.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 1.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 2.4 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.6 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 2.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 7.3 | GO:0007614 | short-term memory(GO:0007614) |
0.6 | 3.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 3.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 2.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 2.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.6 | 1.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.6 | 1.8 | GO:0003166 | bundle of His development(GO:0003166) |
0.6 | 3.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 2.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 2.3 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.6 | 2.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.6 | 11.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.6 | 4.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 1.7 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.6 | 1.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 1.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.6 | 1.7 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 1.7 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 5.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 1.6 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.5 | 0.5 | GO:0051251 | positive regulation of lymphocyte activation(GO:0051251) |
0.5 | 3.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.6 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 3.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 2.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 1.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 1.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.5 | 0.5 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.5 | 2.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 1.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 2.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 2.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 1.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 6.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.5 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.5 | 2.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 1.0 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.5 | 0.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.5 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 0.5 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.5 | 4.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 1.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 1.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 1.5 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.5 | 0.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.5 | 2.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.5 | 4.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 4.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.5 | 1.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 0.5 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.5 | 1.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 3.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 1.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 1.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.5 | 2.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 4.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.5 | 1.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 2.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.5 | 3.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.5 | 1.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 1.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 4.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 0.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.5 | 0.9 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.5 | 1.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.5 | 0.5 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.5 | 1.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 4.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 1.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 1.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 6.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.5 | 1.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.5 | 5.9 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.5 | 0.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 5.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.4 | 4.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 2.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.4 | 0.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.4 | 1.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 3.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 1.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 2.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 2.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 4.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 1.7 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.4 | 0.4 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.4 | 0.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.4 | 0.4 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 1.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 0.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 2.1 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.4 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.4 | 0.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 0.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 1.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.4 | 2.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 2.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.4 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 0.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 2.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 0.8 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 7.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 9.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 3.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 9.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.4 | 1.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.4 | 1.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 0.8 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.4 | 4.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 2.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 0.8 | GO:0032898 | neurotrophin production(GO:0032898) |
0.4 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 1.2 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.4 | 0.4 | GO:0045472 | response to ether(GO:0045472) |
0.4 | 0.8 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 1.9 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 3.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 2.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 0.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 5.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 1.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 2.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 0.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 2.6 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.4 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 5.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 0.4 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.4 | 1.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 1.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.4 | 1.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.4 | 1.5 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 1.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 1.1 | GO:0015802 | basic amino acid transport(GO:0015802) histidine transport(GO:0015817) |
0.4 | 2.2 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 1.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 1.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 0.7 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.4 | 2.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 1.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 1.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 1.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 4.6 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.4 | 0.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 0.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 0.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.4 | 1.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 0.7 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 4.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.7 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 2.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 1.0 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 3.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 1.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 3.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.3 | 0.7 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.3 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 3.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 0.7 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.3 | 2.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 1.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 2.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 0.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 1.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 4.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 1.0 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 1.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 1.0 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.3 | 0.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 0.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 3.3 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 1.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.0 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 1.6 | GO:0051645 | Golgi localization(GO:0051645) |
0.3 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 1.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 1.0 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.3 | 2.5 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 0.3 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 0.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 0.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 1.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.3 | 2.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 2.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 0.3 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 0.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 1.5 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 2.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.9 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 0.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 0.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 1.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 0.3 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.3 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.9 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 5.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 3.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 1.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 5.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 2.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.3 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 1.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 4.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.3 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 3.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 0.9 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.3 | 0.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 2.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 2.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 2.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 2.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 0.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.3 | 1.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
0.3 | 0.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 4.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 1.1 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.6 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 1.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 1.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.8 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 0.6 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.3 | 0.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.3 | 0.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.6 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 1.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.8 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 0.5 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 0.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 1.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.3 | 1.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 1.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.5 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 1.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.8 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.3 | 1.1 | GO:1901300 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 3.2 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 1.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 0.8 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 0.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 4.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.8 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 1.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 1.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.3 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 2.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 1.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 3.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 0.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 3.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 0.8 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 0.3 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.3 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 2.8 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 1.0 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 1.0 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.3 | 1.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.3 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 1.3 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.3 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.3 | 1.3 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.3 | 2.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 3.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 0.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.2 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.2 | 0.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 1.0 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.2 | 0.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 1.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.5 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 1.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 2.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 1.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 7.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.5 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.2 | GO:0043307 | eosinophil activation(GO:0043307) |
0.2 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 1.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.2 | 1.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 1.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 4.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 0.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.2 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.2 | 0.2 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.2 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.5 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.2 | 0.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 0.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 0.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 0.5 | GO:0006189 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.7 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.2 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.4 | GO:0009838 | abscission(GO:0009838) |
0.2 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.4 | GO:0071692 | sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 2.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.2 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 3.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 7.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 1.3 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.7 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 3.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.7 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 1.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 2.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.9 | GO:0045006 | DNA deamination(GO:0045006) |
0.2 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.4 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.2 | 0.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 2.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.2 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 6.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 1.0 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 9.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.2 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 1.0 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 1.2 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 1.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.2 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 4.1 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 3.0 | GO:0071514 | genetic imprinting(GO:0071514) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 2.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.2 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.2 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.2 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.2 | 0.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 3.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 1.4 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.2 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.2 | 1.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.6 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.2 | 2.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 0.4 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.2 | 1.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 2.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 2.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.6 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 4.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 3.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 2.3 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 1.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 3.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.2 | GO:0036503 | ERAD pathway(GO:0036503) |
0.2 | 0.4 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 1.0 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 0.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 4.2 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.2 | GO:0060592 | mammary gland formation(GO:0060592) mammary gland specification(GO:0060594) |
0.2 | 0.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.6 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.8 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.2 | 0.2 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 1.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 1.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 1.7 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 1.5 | GO:0090505 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
0.2 | 0.6 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.2 | 0.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 6.7 | GO:0006096 | glycolytic process(GO:0006096) |
0.2 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.2 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 7.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.5 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 2.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 3.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.5 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 1.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.4 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 1.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 1.8 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.7 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.2 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.2 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 2.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.2 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.2 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 0.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.5 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.3 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.7 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.5 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.3 | GO:0046456 | leukotriene biosynthetic process(GO:0019370) icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.2 | 0.5 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 2.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.7 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 2.7 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 4.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 2.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.2 | 1.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.3 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.2 | GO:0043471 | regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
0.2 | 0.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.7 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 3.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 3.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.2 | 2.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 1.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.8 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 2.9 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.2 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.8 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 1.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 1.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.9 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.2 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 0.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 1.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 0.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.2 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.2 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.2 | 0.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 2.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.7 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 1.0 | GO:0031125 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) rRNA 3'-end processing(GO:0031125) |
0.1 | 2.6 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 8.1 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.9 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.7 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.3 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 2.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.1 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.3 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 1.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 2.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 3.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 1.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 5.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 1.9 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 3.6 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.3 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.3 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.1 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 1.1 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.3 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 2.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 1.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 1.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.1 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.3 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 3.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.4 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.1 | 2.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 2.7 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 4.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.1 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.1 | 1.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 1.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.5 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.1 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 1.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.6 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.1 | 0.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 2.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 1.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 4.2 | GO:0001889 | liver development(GO:0001889) |
0.1 | 0.6 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 3.9 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 1.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 1.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.2 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 3.6 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 3.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.7 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 9.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 3.9 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.8 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 1.1 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 1.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 2.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 1.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 5.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 1.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.2 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.1 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.1 | 2.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 1.7 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 1.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 1.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.8 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.5 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 2.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.6 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 4.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.2 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 2.9 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 2.2 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.1 | 0.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 2.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 2.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 3.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.1 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.1 | 0.2 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.2 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.1 | 0.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 6.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 1.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.2 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.1 | 1.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.2 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 0.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 2.1 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 1.4 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.5 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.3 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.4 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.2 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.1 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.4 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.2 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 10.0 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.6 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.1 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.7 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.4 | GO:0051904 | pigment granule transport(GO:0051904) |
0.1 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.3 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 1.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.6 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 1.4 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.6 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.5 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.2 | GO:0072537 | fibroblast activation(GO:0072537) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 2.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.1 | 0.3 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 2.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.5 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.5 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.2 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.1 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.4 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.1 | 0.4 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.2 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.1 | 1.6 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 1.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 2.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.8 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 1.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.8 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.2 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.3 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 2.5 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0048820 | anagen(GO:0042640) hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.1 | 0.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.1 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.7 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.7 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 0.3 | GO:0052803 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound metabolic process(GO:0052803) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 2.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.2 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.0 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 1.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 2.4 | GO:0030282 | bone mineralization(GO:0030282) |
0.1 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 1.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 1.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.2 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.1 | 0.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 1.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 2.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.1 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.4 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.8 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0051875 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 1.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 3.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.7 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 1.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.6 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.5 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.7 | GO:0009411 | response to UV(GO:0009411) |
0.1 | 0.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 1.3 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.7 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.1 | GO:0072239 | metanephric glomerulus vasculature development(GO:0072239) |
0.1 | 0.5 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.3 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.1 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 0.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.1 | GO:2001055 | endothelial cell fate commitment(GO:0060839) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.3 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.5 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 1.2 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.5 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
0.1 | 0.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.1 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.1 | 0.3 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.1 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.1 | 0.3 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.1 | 1.3 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.1 | 0.1 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 1.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 6.3 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 0.3 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.1 | 1.2 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.1 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.1 | 0.8 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 1.4 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.1 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 1.2 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.9 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 1.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.1 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 2.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.9 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.1 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.2 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.7 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.4 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.3 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:2000286 | regulation of endosome size(GO:0051036) receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.8 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 2.1 | GO:0042060 | wound healing(GO:0042060) |
0.0 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 4.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.4 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.0 | 0.0 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.2 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.0 | 0.5 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.0 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.0 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:1905153 | regulation of membrane invagination(GO:1905153) |
0.0 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 3.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.3 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.7 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.5 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.1 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.4 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.4 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0045912 | negative regulation of carbohydrate metabolic process(GO:0045912) |
0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 1.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 3.1 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 1.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.4 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.0 | 0.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.3 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.8 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.0 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 1.5 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0046208 | polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.5 | GO:0034330 | cell junction organization(GO:0034330) |
0.0 | 1.8 | GO:0010876 | lipid localization(GO:0010876) |
0.0 | 0.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.0 | 1.1 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.2 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.0 | 0.3 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.0 | 0.0 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.0 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.2 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 2.9 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.3 | GO:0045619 | regulation of lymphocyte differentiation(GO:0045619) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.0 | 0.1 | GO:0097009 | energy homeostasis(GO:0097009) |
0.0 | 0.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.4 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.8 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.5 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.0 | 0.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.0 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.0 | 0.0 | GO:0072331 | signal transduction by p53 class mediator(GO:0072331) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.2 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.8 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.0 | 0.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.0 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.0 | 0.3 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0003143 | embryonic heart tube morphogenesis(GO:0003143) |
0.0 | 0.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 1.0 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.4 | GO:0007281 | germ cell development(GO:0007281) |
0.0 | 0.0 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.0 | GO:0050921 | positive regulation of chemotaxis(GO:0050921) |
0.0 | 0.7 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.0 | 0.1 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 1.4 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0009262 | deoxyribonucleotide metabolic process(GO:0009262) |
0.0 | 0.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.9 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.3 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.0 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.2 | GO:0050821 | protein stabilization(GO:0050821) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.3 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 2.6 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.0 | 0.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.0 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0022412 | cellular process involved in reproduction in multicellular organism(GO:0022412) |
0.0 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.0 | GO:0051882 | mitochondrial depolarization(GO:0051882) regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0097413 | Lewy body(GO:0097413) |
1.5 | 4.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.3 | 3.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.1 | 4.5 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 3.4 | GO:0097513 | myosin II filament(GO:0097513) |
1.1 | 3.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.1 | 3.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.0 | 3.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.0 | 3.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.9 | 4.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 2.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 4.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 3.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 3.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.8 | 2.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.8 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 3.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 2.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 3.6 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 2.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.7 | 5.6 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 2.0 | GO:0033267 | axon part(GO:0033267) |
0.7 | 2.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.7 | 6.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 3.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 6.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 2.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 8.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.6 | 7.4 | GO:0036038 | MKS complex(GO:0036038) |
0.6 | 1.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.5 | 2.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.1 | GO:0031252 | cell leading edge(GO:0031252) |
0.5 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 1.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 3.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 3.6 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 2.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 3.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 4.4 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 5.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 1.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 2.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 3.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 2.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 0.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.5 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 2.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 2.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 3.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 2.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 1.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 1.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 1.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 3.8 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.4 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 2.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 4.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 2.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 1.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.7 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 4.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 0.3 | GO:0044421 | extracellular region part(GO:0044421) |
0.3 | 7.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 1.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 1.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 6.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.6 | GO:0043256 | laminin complex(GO:0043256) |
0.3 | 0.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 1.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 2.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 3.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 2.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 1.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.3 | 8.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 3.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 2.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.4 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.2 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 4.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 2.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.6 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 1.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 4.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 2.4 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 1.3 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.3 | 1.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 3.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.3 | 1.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 4.1 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 2.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 1.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 3.9 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 5.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 1.7 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.2 | 2.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 10.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 2.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 5.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 2.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 14.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 2.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 2.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 3.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 2.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 8.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 4.5 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.8 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 2.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 2.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 3.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 2.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 4.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 4.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 0.6 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 16.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 2.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 5.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 53.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 9.4 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 12.4 | GO:0031674 | I band(GO:0031674) |
0.2 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 1.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.5 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 2.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 3.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.7 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 1.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 3.1 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 6.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 7.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.6 | GO:0033179 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.7 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 3.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 7.3 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 35.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.2 | 0.2 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.2 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.8 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 3.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 2.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 7.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 3.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 2.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 2.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.6 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.6 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 3.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 1.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 2.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 11.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 1.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 45.1 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 1.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 2.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 39.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 2.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 14.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.3 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 31.7 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 2.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.5 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 152.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 22.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 3.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.1 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 10.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 4.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 2.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 1.1 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 82.7 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 2.9 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.5 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 2.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 5.0 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 5.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 80.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 44.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.5 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 13.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 2.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.4 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 5.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.2 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.1 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.1 | 1.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 17.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 63.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.7 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 2.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 4.7 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.5 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 1.0 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.4 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 3.7 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 71.8 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.0 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.3 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.0 | 0.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 8.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 3.7 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.3 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 5.3 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 21.9 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.4 | GO:0043234 | protein complex(GO:0043234) |
0.0 | 31.4 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 10.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.1 | 8.3 | GO:0009374 | biotin binding(GO:0009374) |
2.0 | 6.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.6 | 4.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
1.6 | 8.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.6 | 4.8 | GO:0030172 | troponin C binding(GO:0030172) |
1.5 | 4.6 | GO:0048030 | disaccharide binding(GO:0048030) |
1.5 | 6.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.3 | 3.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.3 | 7.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.3 | 8.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.1 | 4.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 6.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.0 | 7.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.0 | 2.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.9 | 7.3 | GO:0008430 | selenium binding(GO:0008430) |
0.9 | 2.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.8 | 2.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 2.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 3.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 7.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 2.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 3.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.8 | 4.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 3.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 3.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 2.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 2.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 2.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 3.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 2.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 12.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 3.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 16.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.7 | 2.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 2.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.7 | 2.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.7 | 2.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 3.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.7 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.7 | 2.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 2.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 2.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 7.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 7.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 1.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 1.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.6 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 4.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.6 | 1.8 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.6 | 1.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.6 | 2.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 3.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.6 | 4.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.5 | 1.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.5 | 3.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.5 | 2.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 2.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.5 | 2.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 5.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.5 | 1.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 4.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 2.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.5 | 17.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.5 | 1.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 2.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 3.1 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.5 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 3.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 1.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 2.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 2.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.5 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 0.5 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.5 | 5.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 2.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 1.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 7.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 5.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 4.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 2.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 4.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 1.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 1.3 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 1.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 0.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.4 | 8.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 2.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 3.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 2.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 4.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 2.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 0.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.4 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 2.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 1.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 8.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 3.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 1.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 1.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 0.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 1.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 0.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.4 | 1.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.4 | 6.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.4 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 4.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 4.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.3 | 2.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 3.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 3.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 2.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 2.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.3 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 6.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 4.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 2.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 0.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 2.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 0.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 1.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 10.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 4.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 2.1 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 3.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 2.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 2.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 2.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 3.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 9.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 23.5 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 2.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 2.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 2.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.5 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.3 | 3.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 4.3 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 2.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.3 | 2.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 3.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.6 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 7.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 2.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 3.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 1.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 1.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 6.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 1.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 2.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.5 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 1.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 4.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.2 | 4.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 1.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 4.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 3.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 2.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 4.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 3.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 2.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 11.7 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 5.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 6.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 6.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.9 | GO:0052687 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 2.6 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 15.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.2 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 6.5 | GO:0018731 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 2.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 2.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 2.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 6.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 2.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 3.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 2.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 3.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 1.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 2.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 3.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.8 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 8.9 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 8.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 1.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 2.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 3.8 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 1.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 12.8 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.7 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 6.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 12.3 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 3.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 6.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 5.3 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 3.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 5.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 1.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 4.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 5.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 5.8 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.8 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 2.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.2 | GO:0016723 | ferric-chelate reductase activity(GO:0000293) oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 2.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 3.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 3.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.2 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 2.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.2 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 4.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 3.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 2.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 5.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 1.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 1.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 6.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.6 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 1.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.4 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 3.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 2.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.9 | GO:0034061 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.7 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.1 | 1.2 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.8 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 3.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 2.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 6.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 1.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 6.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 1.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 2.9 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 9.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 2.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 3.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 2.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.8 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 2.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.7 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.1 | 3.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 1.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 4.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.7 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 2.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 4.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 2.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 8.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 13.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 1.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.1 | 0.9 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.1 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 12.2 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.8 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 5.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 7.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0043121 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 14.6 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
0.1 | 14.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.3 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 3.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 2.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 3.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 16.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 2.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 7.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 4.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 2.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 2.6 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 2.3 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 14.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 8.4 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.7 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 2.3 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.7 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 2.6 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 5.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 2.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0034548 | GTP cyclohydrolase activity(GO:0003933) N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 3.9 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 10.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 2.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 3.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.4 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 6.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.1 | 0.5 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 2.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 17.0 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.1 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 20.1 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.4 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 2.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 1.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.1 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 20.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 8.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 20.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 1.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 1.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 1.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 6.0 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.0 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.3 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 1.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 1.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 2.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.2 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.2 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 1.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 2.4 | GO:0019901 | protein kinase binding(GO:0019901) |
0.0 | 0.0 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.6 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 2.0 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 5.6 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.0 | 1.3 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 7.0 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 22.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.6 | 9.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 13.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 4.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 13.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 10.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 8.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 8.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.5 | 16.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 4.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 12.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 8.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 2.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 16.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 13.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 5.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 5.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 5.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 3.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 9.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 6.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 5.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 2.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 4.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 9.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 5.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 6.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 6.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 3.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 3.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 9.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 5.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 17.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 10.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 5.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 1.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 3.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 4.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 3.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.1 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 22.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 6.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 8.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 7.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 4.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 11.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 5.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 5.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 1.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 5.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 3.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 0.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 4.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 4.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 6.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 4.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 4.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 4.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.4 | 6.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 4.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 3.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 10.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 6.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 8.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 7.8 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 6.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 2.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 5.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.7 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.3 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 7.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 2.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 15.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 1.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 2.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 2.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 1.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 4.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 5.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 2.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 4.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 3.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 1.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 4.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 1.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 3.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 3.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 1.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 3.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 5.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 3.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 2.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 6.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 5.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 4.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 7.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 11.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 2.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 6.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 8.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 2.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 3.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 2.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 4.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 2.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 1.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 6.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 16.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 6.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 2.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 5.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 3.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 12.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 7.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 1.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 1.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 11.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 9.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 2.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 2.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 2.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 6.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 2.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 3.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 14.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 6.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 3.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 3.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 11.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 3.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 4.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 18.9 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 2.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 2.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 2.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.3 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 2.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.7 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 9.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 5.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 3.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 4.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 3.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 5.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.8 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.9 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 2.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.2 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |